Medigene AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was EUR 3.06 million compared to EUR 25.28 million a year ago. Net loss was EUR 6.97 million compared to net income of EUR 13.92 million a year ago. Basic loss per share from continuing operations was EUR 0.28 compared to basic earnings per share from continuing operations of EUR 0.57 a year ago.